Artwork

Kandungan disediakan oleh Sano Genetics. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Sano Genetics atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !

EP 168: A world-first in RNA medicines with Erik Ingelsson, Chief Scientific Officer at Wave Life Sciences

37:54
 
Kongsi
 

Manage episode 458944960 series 2631947
Kandungan disediakan oleh Sano Genetics. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Sano Genetics atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
0:00 Intro to The Genetics Podcast

01:00 Welcome to Erik

02:05 Key differences between DNA and RNA editing

05:25 Wave’s recent world-first finding in Alpha-1 Antitrypsin Deficiency

08:17 Dosage regularity and delivery process for edited RNA therapies

14:08 Next steps for Wave’s new discovery, including potential applications in other conditions

17:41 Using genetic targets to inform areas of focus and RNA treatment development

24:04 The GLP1 mechanism in human genetics and its role in obesity

25:43 Erik’s transition from big pharma to biotech and the resulting changes in his approach to treatment development

31:02 What has driven Erik to explore and experience a wide range of roles throughout his career

34:29 The importance of balancing fatherhood with a thriving career, and how Erik works to do so successfully

38:35 Closing remarks

Find out more

Please consider rating and reviewing us on your chosen podcast listening platform!

  continue reading

199 episod

Artwork
iconKongsi
 
Manage episode 458944960 series 2631947
Kandungan disediakan oleh Sano Genetics. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Sano Genetics atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
0:00 Intro to The Genetics Podcast

01:00 Welcome to Erik

02:05 Key differences between DNA and RNA editing

05:25 Wave’s recent world-first finding in Alpha-1 Antitrypsin Deficiency

08:17 Dosage regularity and delivery process for edited RNA therapies

14:08 Next steps for Wave’s new discovery, including potential applications in other conditions

17:41 Using genetic targets to inform areas of focus and RNA treatment development

24:04 The GLP1 mechanism in human genetics and its role in obesity

25:43 Erik’s transition from big pharma to biotech and the resulting changes in his approach to treatment development

31:02 What has driven Erik to explore and experience a wide range of roles throughout his career

34:29 The importance of balancing fatherhood with a thriving career, and how Erik works to do so successfully

38:35 Closing remarks

Find out more

Please consider rating and reviewing us on your chosen podcast listening platform!

  continue reading

199 episod

ทุกตอน

×
 
Loading …

Selamat datang ke Player FM

Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.

 

Panduan Rujukan Pantas

Podcast Teratas
Dengar rancangan ini semasa anda meneroka
Main